Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Safety

Adverse Effects

Kissei Tells Japan Doctors to Halt New Tavneos Use After 20 Deaths Reported

The move signals growing global pressure on Amgen’s vasculitis drug during widening safety and data reviews.

Lilly’s Oral Foundayo Matches Insulin on Heart Safety in Major Diabetes Trial

FDA Flags 76 Liver Injuries Linked to Amgen’s Tavneos, Urges Tight Monitoring

FDA Warns Novo Nordisk Over Missed Reporting of Serious Semaglutide and GLP-1 Adverse Events

Pirtobrutinib Extends First-Line PFS vs BR and Shows Higher Response Rates Than Ibrutinib in CLL/SLL

Gwalior Hospital Halts Azithromycin Batch After Complaint of Worm‑Like Particles

WHO Flags Three Toxic Cough Syrups in India as Tamil Nadu Shuts Coldrif Maker

Toxic Coldrif Batch Linked to 14 Child Deaths in MP; Doctor Arrested as Centre Launches Inspections

FDA Restricts Moderna and Novavax COVID-19 Vaccines to Seniors and Vulnerable Groups

UK Regulator Probes Pancreatitis Cases Linked to GLP-1 Weight-Loss Drugs